CD19 and cancer: Simultaneous assessment of CD45 and CD56 together with (surface membrane and cytoplasmic) CD3 and CD19, as well as numyogenin, EpCAM, CD271, and GD2, provides fast and highly accurate diagnostic orientation in children suspicious of having cancer.